References
- Martindale, The Complete Drug Reference, 35th ed., Pharmaceutical Press, London 2007, p. 1723.
- M. N. Madhat, Buccal and Sublingual Administration of Physostigmine, U.S. Pat. 6,264,974, 24 Jul 2001.
- R. Whelpton and P. Hurst, Bioavailability of oral physostigmine, New Eng. J. Med. 313 (1985) 1293-1294.
- D. Harris and J. R. Robinson, Drug delivery via the mucous membranes of the oral cavity, J. Pharm. Sci. 81 (1992) 1-10; DOI: 10.1002/jps.2600810102.
- P. Mura, S. Furlanetto, M. Cirri, F. Maestrelli, A. M. Marras and S. Pinzauti, Optimization of glibenclamide tablet composition through the combined use of differential scanning calorimetry and D-optimal mixture experimental design, J. Pharm. Biomed. Anal. 37 (2005) 65-71.
- R. C. Hwang and D. L. Kowalski, Design of experiments for formulation development, Pharm Tech Dec 1, 2005.
- Introduction to Experimental Design, in Pharmaceutical Experimental Design and Interpretation, 2nd ed., N. A. Armstrong (Ed.), Taylor & Francis, London 2006, pp. 1-8.
- X. Jin, Y. Zhang, L. Xiao and Z. Zhao, Optimization of extended zero-order release gliclazide tablets using D-optimal mixture design, J. Pharm. Soc. Japan 128 (2008) 1475-1483.
- Y. El-Malah, S. Nazzal and N. M. Khanfar, D-optimal mixture design: optimization of ternary matrix blends for controlled zero-order drug release from oral dosage forms, Drug Dev. Ind. Pharm. 32 (2006) 1207-1218; DOI: 10.1080/03639040600685167.
- S. S. Patel, S. Ray and R. S. Thakur, Formulation and evaluation of floating drug delivery system containing clarithromycin for Helicobacter pylori, Acta Pol. Pharm. 63 (2006) 53-61.
- Y. Gonnissen, S. I. Gonçalves, J. P. Remon and C. Vervaet, Mixture design applied to optimize a directly compressible powder produced via cospray drying, Drug Dev. Ind. Pharm. 34 (2008) 248-257; DOI: 10.1080/03639040701542143.
- T. Nahata and T. R. Saini, D-optimal designing and optimization of long acting microsphere-based injectable formulation of aripiprazole, Drug Dev. Ind. Pharm. 34 (2008) 668-675; DOI: 10.1080/03639040701836545.
- A. Bodea and S. E. Leucuta, Optimization of hydrophilic matrix tablets using a D-optimal design, Int. J. Pharm. 153 (1997) 247-255; DOI: 10.1016/S0378-5173(97)00117-8.
- R. C. Rowe, P. J. Sheskey and P. J. Weller, Handbook of Pharmaceutical Excipients, 5th ed., Pharmaceutical Press and American Pharmaceutical Association, London 2006.
- United States Pharmacopeia 31, National Formulary 26, The United States Pharmacopeial Convention, Rockville 2008.
- S. J. Ugarkovic, Sublingual Oral Dosage Form, U.S. Pat. 6,572,891, 3 Jun 2003.
- G. Derringer and R. Suich, Simultaneous optimization of several response variables, J. Qual. Tech. 12 (1980) 214-219.
- H. L. Fung, S. K. Yap and C. T. Rhodes, Development of a stable sublingual nitroglycerin tablet II: formulation and evaluation of tablets containing povidone, J. Pharm. Sci. 65 (1976) 558-560; DOI: 10.1002/jps.2600650419.
- C. P. Lim, S. S. Quek and K. K. Peh, Prediction of drug release profiles using an intelligent learning system: an experimental study in transdermal iontophoresis, J. Pharm. Biomed. Anal. 31 (2003) 159-168; DOI: 10.1016/S0731-7085(02)00573-3.
- J. Klancke, Dissolution testing of orally disintegrating tablets, Diss. Tech. 10 (2003) 6-8.